YOLO vs. ARKG ETF Comparison
Comparison of AdvisorShares Pure Cannabis ETF (YOLO) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
YOLO
AdvisorShares Pure Cannabis ETF
YOLO Description
Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.
Grade (RS Rating)
Last Trade
$4.01
Average Daily Volume
75,455
10
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$25.52
Average Daily Volume
2,356,093
37
Performance
| Period | YOLO | ARKG |
|---|---|---|
| 30 Days | -5.42% | -4.46% |
| 60 Days | 22.44% | -16.11% |
| 90 Days | 4.68% | -14.39% |
| 12 Months | 36.26% | -14.10% |
0 Overlapping Holdings
| Symbol | Grade | Weight in YOLO | Weight in ARKG | Overlap |
|---|
YOLO Underweight 37 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| CRSP | F | -7.23% | |
| TWST | A | -6.83% | |
| RXRX | F | -5.57% | |
| EXAS | D | -5.28% | |
| SDGR | F | -4.54% | |
| IONS | D | -4.52% | |
| ACCD | F | -3.98% | |
| NTLA | F | -3.73% | |
| BEAM | F | -3.59% | |
| ARCT | F | -3.56% | |
| TXG | F | -3.54% | |
| TDOC | F | -3.5% | |
| CDNA | C | -3.43% | |
| MRNA | B | -3.21% | |
| DNA | F | -3.18% | |
| VCYT | F | -2.96% | |
| VEEV | D | -2.88% | |
| VRTX | D | -2.73% | |
| NRIX | D | -2.52% | |
| ADPT | D | -2.13% | |
| MASS | F | -1.74% | |
| INCY | D | -1.62% | |
| QSI | C | -1.59% | |
| VERV | F | -1.45% | |
| CMPS | D | -1.31% | |
| PACB | F | -1.29% | |
| REGN | C | -1.22% | |
| PATH | F | -1.16% | |
| ABSI | C | -1.13% | |
| CERS | F | -1.08% | |
| AMGN | B | -1.07% | |
| PRME | F | -1.01% | |
| RPTX | F | -0.66% | |
| PSNL | C | -0.63% | |
| BFLY | F | -0.62% | |
| NTRA | A | -0.58% | |
| GH | D | -0.48% |
YOLO: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords
Compare ETFs
